Diagnosis and evaluation of prognosis of myelofibrosis: a British Society for Haematology Guideline by McLornan, DP, Godfrey, AL, Green, A, Frewin, R, Arami, S, Brady, J, Butt, NM, Cargo, C, Ewing, J, Francis, S, Garg, M, Harrison, C, Innes, A, Khan, A, Knapper, S, Lambert, J, Mead, A, McGregor, A, Neelakantan, P, Psaila, B, Somervaille, TCP, Woodley, C, Nangalia, J, Cross, NCP, McMullin, MF

“…This document represents an update of the British Society for Haematology (BSH) guideline on myelofibrosis (MF) first published in 2012 and updated in 2015.1 This guideline aims to provide healthcare professionals with clear guidance on the diagnosis and prognostic evaluation of primary myelofibrosis (PMF), as well as post-polycythaemia vera myelofibrosis (post-PV MF) and post-essential thrombocythaemia myelofibrosis (post-ET MF). …”

A guideline for the diagnosis and management of polycythaemia vera. A British Society for haematology guideline by McMullin, M, Harrison, C, Ali, S, Cargo, C, Chen, F, Ewing, J, Garg, M, Godfrey, A, Knapper, S, McLornan, D, Nangalia, J, Sekhar, M, Wadelin, F, Mead, A

The use of viscoelastic haemostatic assays in the management of major bleeding: A British Society for Haematology Guideline by Curry, NS, Davenport, R, Pavord, S, Mallett, SV, Kitchen, D, Klein, AA, Maybury, H, Collins, PW, Laffan, M

A physician survey on the application of the British Society for Haematology guidelines for the diagnosis and management of myelofibrosis in the UK by Harrison, C, Mead, A, Drummond, M, Chiu, G, Bains, R

The Use of Next-generation Sequencing in the Diagnosis of Rare Inherited Anaemias: A Joint BSH/EHA Good Practice Paper by Noémi B. A. Roy, Lydie Da Costa, Roberta Russo, Paola Bianchi, Maria del Mar Mañú-Pereira, Elisa Fermo, Immacolata Andolfo, Barnaby Clark, Melanie Proven, Mayka Sanchez, Richard van Wijk, Bert van der Zwaag, Mark Layton, David Rees, Achille Iolascon, on behalf of the British Society for Haematology and the European Hematology Association

Get full text

The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders by Cross, NCP, Godfrey, AL, Cargo, C, Garg, M, Mead, AJ

Impaired antibody response to COVID-19 vaccination in patients with chronic myeloid neoplasms by Chowdhury, O, Bruguier, H, Mallett, G, Sousos, N, Crozier, K, Allman, C, Eyre, D, Lumley, S, Strickland, M, Karali, CS, Murphy, L, Sternberg, A, Jeffery, K, Mead, AJ, Peniket, A, Psaila, B

Combination romidepsin and azacitidine therapy is well tolerated and clinically active in adults with high-risk acute myeloid leukaemia ineligible for intensive chemotherapy by Loke, J, Metzner, M, Boucher, R, Jackson, A, Hopkins, L, Pavlu, J, Tholouli, E, Drummond, M, Peniket, A, Bishop, R, Fox, S, Vyas, P, Craddock, C

Guideline for the investigation and management of eosinophilia by Butt, N, Lambert, J, Ali, S, Beer, P, Cross, N, Duncombe, A, Ewing, J, Harrison, C, Knapper, S, McLornan, D, Mead, A, Radia, D, Bain, B

“…The guideline was then reviewed by a sounding board of UK haematologists and representatives from the Nordic MPN Study Group, the British Committee for Standards in Haematology (BCSH) and the British Society for Haematology (BSH) Committee and comments were incorporated where appropriate. …”

Guideline for the diagnosis and management of myelofibrosis. by Reilly, J, McMullin, M, Beer, P, Butt, N, Conneally, E, Duncombe, A, Green, A, Michaeel, N, Gilleece, M, Hall, G, Knapper, S, Mead, A, Mesa, R, Sekhar, M, Wilkins, B, Harrison, C

“…The guideline was then reviewed by a sounding board of UK haematologists, the BCSH and the British Society for Haematology Committee and comments incorporated where appropriate. …”

A left shift in the oxyhaemoglobin dissociation curve in patients with severe coronavirus disease 2019 (COVID-19) by Vogel, DJ, Formenti, F, Retter, AJ, Vasques, F, Camporota, L

Guideline for the diagnosis and management of myelofibrosis by Reilly, J, Mcmullin, M, Beer, P, Butt, N, Conneally, E, Duncombe, A, Green, A, Michaeel, N, Gilleece, M, Hall, G, Knapper, S, Mead, A, Mesa, R, Sekhar, M, Wilkins, B, Harrison, C

“…The guideline was then reviewed by a sounding board of UK haematologists, the BCSH and the British Society for Haematology Committee and comments incorporated where appropriate. …”

Guidelines for the investigation and management of Transient Leukaemia of Down Syndrome by Tunstall, O, Bhatnagar, N, James, B, Norton, A, O'Marcaigh, AS, Watts, T, Greenough, A, Vyas, P, Roberts, IAG, Wright, M

“…<p><strong>Methodology</strong> This guideline was compiled according to the British Society for Haematology (BSH) process at (http://www.bcshguidelines.com). …”

National comparative audit of red blood cell transfusion practice in hospices: Recommendations for palliative care practice by Neoh, K, Gray, R, Grant-Casey, J, Malia, C, Boland, J, Bennett, M, Estcourt, L

“…</p> <h4>Aim</h4> <p>To determine national transfusion practice in hospices and compare this against National Institute for Health and Care Excellence and British Society of Haematology guidelines to develop recommendations to improve practice.…”

Endovascular Treatment of Aortic Aneurysms and Blood Transfusion. What do We Need? by Rui Machado, Luís Loureiro, Inês Antunes, Jorge Coutinho, Rui Almeida

“…Discussion: Guidelines from the British Society of Haematology are based on a crossmatch to transfusion ratio of 2:1. …”
Get full text

Hapticophagia in Iron Deficiency Anaemia and Oral Submucous Fibrosis- Two Sides of the Same Coin by P Poornachitra, Arvind Muthukrishnan

“…For arriving at the diagnosis of IDA, the American Society of Haematology (ASH) and the British Society of Haematology (BSH) [16] and the BSH [17] recommend the Complete Blood Count (CBC) or Full Blood Count (FBC). …”
Get full text